Decision Diagnostics Corp (DECN)

[IPwatcher]

REPLY RECEIVED FROM PAUL EHRLICH INSTITUTE:

Dear ....
we would like to point out that we only evaluate antigen tests that are listed at the BfArM in accordance with the Coronavirus Test Ordinance - TestV. You also should be aware that we only conduct the evaluation of SARS-CoV-2 rapid antigen tests, for which manufacturers ask for. We do not evaluate all antigen tests listed on BfArM. Because of this, you can find the mentioned test on the BfArM list although PEI has not conducted an evaluation yet.
In conclusion, we can make a recommendation for deletion from the BfArM list according to the requirements of the Paul Ehrlich Institute (PEI) minimum criteria defined in coordination with the Robert Koch Institute (RKI) after the test has been evaluated by us.

Best Regards,
(name supplied)

PEI – IVD
Wissenschaftliche Mitarbeiterin

KEY POINTS:
1. Pedima/DECN have not asked for PEI evaluation.
Now why would that be???
Until they do (and they won't) PEI can't delist them!

So that BfarM listing is proof of NOTHING other than that Pedima says DECN claims it has a test and some data

It constitutes ZERO actual evidence of the existence, let alone the performance of the Genviro diagnostic. It is just an unverified record of what a manufacturer (currently facing fraud charges) has publicly claimed! NOTHING MORE!